More than a week has passed since Boston Scientific, a major American medical device manufacturer, began experiencing visible limitations in its operations. The company detected a cybersecurity incident on August 25, which led to a significant disruption of its network. This outage has affected all computer operations, including access to key operating systems and business applications. As a result, Boston Scientific has faced challenges in manufacturing, processing, and shipping customer orders. The situation has remained largely unchanged since the initial detection, with no signs of unauthorized activity on the network since that date. Boston Scientific has confirmed that it can still receive electronic orders, but they are placed on hold for later processing. However, the company has not yet provided a clear timeline for full recovery. In an update released on August 30, Boston Scientific detailed the impact of the incident on its medical devices. This includes systems used to program or monitor pacemakers, which are critical for patients with heart conditions. The company is now facing specific challenges with the remote monitoring of cardiac devices implanted since the start of the incident. For new rhythm management devices, such as pacemakers, Boston Scientific can no longer activate the communicator used for remote monitoring. This means that data collected by the implant is not automatically sent to the systems used by medical teams. Similarly, new implantable cardiac monitors (ICMs), which record the electrical activity of the heart without delivering treatment, are affected. These small devices can no longer be linked to the patient’s mobile application, blocking automated data transmission. However, the company assures that the therapeutic function of pacemakers and other rhythm management devices remains unaffected. ICMs continue to record any potential cardiac episodes, but this information must be manually retrieved during a consultation. Patients who had their remote monitoring configured before August 25 are not affected and continue to be monitored normally. At this stage, no credible claims have been made public, and Boston Scientific has not identified the group responsible for the breach, the initial access method, or the exact nature of the attack. The company has not indicated whether data was stolen or if a ransom demand was made. Given the scale of the system disruption and the length of the interruption, the possibility of a ransomware attack cannot be ruled out.